These transformative transactions will position AlliancePharma for the next stage of its corporate development. Assuming the completion of these transactions, AlliancePharma will have approximately 100 employees, a network
Zoptrex, a novel synthetic peptide carrier linked to doxorubicin as a New Chemical Entity (NCE), is currently in a fully-enrolled Phase 3 clinical trial in endometrial cancer. The
The IND was filed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.The Phase 1 trial (designated HVTN 114) will
Citius CEO Myron Holubiak said, "Suprenza no longer meets our core strategic objectives. We are dedicating our focus on our Phase 3 asset Mino-Lok and our Phase 2b
The agreement is the initial stalking horse bid under Section 363 of the U.S. Bankruptcy Code, to be followed by an orderly auction process as established by the
Livingston: Recently Vaisala released the latest build of its viewLinc Environmental Monitoring System. What’s different about this version? Aldous: The previous version of the viewLinc system has long
In the latest 12 months ending March 31, 2016, the Net sales of these brands was approximately $24.4 million. The purchase price is $40 million and Moberg Pharma
The eXalt3 trial is an open-label, randomized study designed to evaluate the efficacy and safety of X-396, the Company’s lead ALK inhibitor drug candidate, versus crizotinib in over
RAVICTI received centralised marketing approval from the European Medicines Agency (EMA) in September 2015. It is indicated for the treatment of Urea Cycle Disorders (UCDs) in adults and
GBT is developing GBT440 as a potential disease-modifying therapy for SCD. "We are pleased to initiate our Phase 2a study of GBT440 in adolescents. The initiation of this
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.